← All trials

NCT03428958

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Oct 16, 2018
Primary completion
Nov 30, 2023
Completion date
Nov 30, 2023
First posted
Feb 12, 2018
Last posted
Jun 29, 2023
Enrollment
225
Arms / groups
15 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.